Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Calgary

University of Calgary in Calgary, Alberta, Canada is listed as a site for 552 registered clinical trials, 151 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 552
Ongoing 151

This page covers the site record University of Calgary in Calgary, Alberta, Canada: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, University of Calgary, also sponsors trials.

Get the University of Calgary report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 552 trials counted.

  • Phase 1 21 trials
  • Phase 1/2 11 trials
  • Phase 2 87 trials
  • Phase 2/3 13 trials
  • Phase 3 110 trials
  • Phase 4 25 trials
  • Not applicable 196 trials
  • Observational 89 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 151 trials
  • Completed 277 trials
  • Terminated 72 trials
  • Other 52 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 42

1999: 2 trials (Observational 1, Phase 3 1) 2000: 2 trials (Phase 3 2) 2002: 3 trials (Not applicable 1, Phase 3 1, Phase 2/3 1) 2003: 9 trials (Not applicable 2, Phase 3 4, Phase 2/3 1, Phase 2 1, Phase 1/2 1) 2004: 6 trials (Phase 4 2, Phase 3 3, Phase 2 1) 2005: 7 trials (Not applicable 1, Phase 3 3, Phase 2/3 1, Phase 2 2) 2006: 8 trials (Observational 1, Not applicable 2, Phase 4 1, Phase 3 3, Phase 2/3 1) 2007: 12 trials (Not applicable 1, Phase 4 1, Phase 3 4, Phase 2/3 1, Phase 2 4, Phase 1 1) 2008: 9 trials (Observational 2, Not applicable 3, Phase 4 1, Phase 3 2, Phase 2 1) 2009: 13 trials (Observational 4, Not applicable 3, Phase 4 2, Phase 3 4) 2010: 8 trials (Observational 1, Not applicable 2, Phase 3 3, Phase 2 1, Phase 1 1) 2011: 25 trials (Observational 4, Not applicable 11, Phase 4 2, Phase 3 2, Phase 2/3 1, Phase 2 4, Phase 1 1) 2012: 21 trials (Observational 3, Not applicable 9, Phase 3 7, Phase 2 2) 2013: 14 trials (Observational 2, Not applicable 6, Phase 3 4, Phase 2 1, Phase 1/2 1) 2014: 21 trials (Observational 4, Not applicable 10, Phase 3 4, Phase 2/3 1, Phase 2 2) 2015: 33 trials (Observational 5, Not applicable 9, Phase 4 1, Phase 3 7, Phase 2 8, Phase 1/2 2, Phase 1 1) 2016: 30 trials (Observational 5, Not applicable 11, Phase 4 5, Phase 3 4, Phase 2/3 1, Phase 2 3, Phase 1 1) 2017: 25 trials (Observational 2, Not applicable 12, Phase 4 2, Phase 3 2, Phase 2 6, Phase 1/2 1) 2018: 39 trials (Observational 4, Not applicable 16, Phase 3 12, Phase 2/3 3, Phase 2 2, Phase 1 2) 2019: 33 trials (Observational 5, Not applicable 9, Phase 3 7, Phase 2 10, Phase 1/2 1, Phase 1 1) 2020: 25 trials (Observational 7, Not applicable 6, Phase 4 2, Phase 3 2, Phase 2 6, Phase 1/2 1, Phase 1 1) 2021: 42 trials (Observational 7, Not applicable 18, Phase 4 2, Phase 3 7, Phase 2/3 2, Phase 2 5, Phase 1 1) 2022: 39 trials (Observational 6, Not applicable 17, Phase 4 1, Phase 3 6, Phase 2 5, Phase 1/2 1, Phase 1 3) 2023: 39 trials (Observational 8, Not applicable 17, Phase 4 2, Phase 3 3, Phase 2 5, Phase 1/2 2, Phase 1 2) 2024: 39 trials (Observational 7, Not applicable 16, Phase 4 1, Phase 3 5, Phase 2 7, Phase 1/2 1, Phase 1 2) 2025: 33 trials (Observational 7, Not applicable 11, Phase 3 5, Phase 2 7, Phase 1 3)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 15
2025 33
2024 39
2023 39
2022 39
2021 42
2020 25
2019 33
2018 39
2017 25

Showing 10 of 27 years.

Start your 14-day trial Email me all 27 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 552 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 108 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 338 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF